Search
Regeneron Pharmaceuticals Inc
REGNAdd to Watchlist
607.730USD
-7.000-1.14%
Close 06/17, 16:00（ET）Quotes delayed by 15 min
63.73BMarket Cap
14.31P/E TTM
Regeneron Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-06-17The current valuation score of Regeneron Pharmaceuticals Inc is 9.35, ranking 30 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 14.31, which is 108.34% below the recent high of 29.82 and 19.20% above the recent low of 11.56.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
